4-minute read
Normes du travail : on va nuire à ceux qu’on veut aider
The impact of Bill 176.
4-minute read
Supreme Court fails to protect Canadians’ economic interests
The Supreme Court ruling in the Comeau case.
4-minute read
Our Governments Shouldn’t ‘Protect’ Us From The Likes Of Facebook
The protection of private data on the Internet.
IEDM – Nouveaux médicaments; les malades attendent trop longtemps – Mathieu Bédard
April 10, 2018 | 14 min. 38 sec. | Boréale 138 (Ici Radio-Canada) Interview (in French) with Mathieu Bédard, Economist at the […]
4-minute read
Innovative drugs need a new regulatory approach
Access to new drugs in Canada.
IEDM – Pourquoi faut-il attendre pour avoir accès à de nouveaux médicaments? – Mathieu Bédard
April 5, 2018 | 26 min. 07 sec. | Isabelle (98.5 FM) Interview (in French) with Mathieu Bédard, Economist at the MEI, […]
IEDM – Nouveaux médicaments : les malades attendent 15 mois de trop – Mathieu Bédard
April 5, 2018 | 14 min. 36 sec. | Québec aujourd’hui (BLVD 102.1 FM) Interview (in French) with Mathieu Bédard, Economist at […]
5-minute read
Protéger la vie privée, mais aussi la liberté de décider pour soi-même
The protection of private data on the Internet.
5-minute read
Nouveaux médicaments : la longue marche réglementaire
Access to new drugs in Canada.
8-minute read
Innovative Drugs: A Bureaucratic Obstacle Course
Innovative drugs help people enjoy longer, healthier, more productive lives. They also allow our health care systems to save money. However, the reimbursement of new drugs by Canada’s public plans can face considerable delays due to a very burdensome regulatory process. Far from resolving this problem, a new reform will duplicate certain stages of this process and possibly lengthen it.